Experts warn that recent legislative proposals may endanger research on the environment and cancer, following a study highlighting the positive association between cancer incidence and poor environment quality.
Browsing: Disease Area > Prostate
Discover the potential role for prostate multiparametric MRI and targeted biopsy techniques incorporating MRI into active surveillance in this article from Future Oncology.
To mark World Health Day, for which the theme this year is depression, Oncology Central spoke with Christopher Sharpley about his research into uncovering novel treatments for depression in prostate cancer patients and his hopes for the future of the field.
In this special report from Future Oncology the authors review the current literature on early salvage radiotherapy post-prostatectomy and provide key insights on the future of this therapy.
In this article from Future Oncology the authors review the current landscape of outlier genes in the field of prostate cancer.
An Ontario-led international clinical trial has determined a new standard of care for patients with localized prostate cancer.
New investigation highlights preclinical efficacy of a combination of immune checkpoint inhibitors and therapies targeting myeloid-derived suppressor cells in advanced prostate cancer.
The goal of this study from Future Science OA is to utilize a novel strategy that combines biological outputs with Bayesian network learning to identify potential biomarkers for prostate cancer.
James Gulley of the National Cancer Institute talks to us about his work developing cancer immunotherapies, his insights into the impact of this modality in prostate cancer and his hopes for the future of the field.